Management tracks: Lonza CEO to step down; plus Arrowhead, Insmed, Inozyme, Yukin, Pfenex, EyePoint, Verseau, Abingworth, CBC, Flagship, Diverse, Theragnostics,

Lonza Group Ltd. (SIX:LONN) CEO Marc Funk will leave the company in January for personal reasons. Chairman Albert Baehny will take on the CEO responsibilities on an interim basis.

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) said COO and Head of R&D Bruce Given will retire on May 1 while remaining an adviser for at least one year. The RNAi company hired Javier San Martin as CMO and Curt Bradshaw as CSO. San Martin was SVP and head of global clinical development at Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Bradshaw was president, CSO and board member at immuno-oncology company Tollnine, which he co-founded...